Based on cytogenetic, genetic and epigenetic alterations found in MDS-BM, MDS phenotypes are considered to arise from impaired maturation and differentiation of CD34+CD38− hematopoietic stem cells (HSCs) [10–17]. The gene discussed is CD38; the disease is myelodysplastic syndrome.